Vallon Pharmaceuticals Accounts Payable

Vallon Pharmaceuticals (VLON) currently reports a accounts payable of $1.4M as of March 2025. That compares with $640K in the prior-year period — up 113.7% year over year. Use the charts on this page to explore Vallon Pharmaceuticals's accounts payable history and peer comparisons.

Vallon Pharmaceuticals's accounts payable increased from $640K to $1.4M — a 113.7% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vallon Pharmaceuticals reported $1.4M in accounts payable as of March 2025. That compares with $640K in the prior-year period — up 113.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vallon Pharmaceuticals, and consider following VLON for alerts when major investors trade the stock.

Vallon Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $1.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VLON with unrelated industries.